Showing results (21-30 of 87) with videos related to
Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|January 30, 2023
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 InfectionTakuya Tada, Belinda M Dcosta, Julia Minnee, et al.Iscience|February 6, 2023
Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal modelTakuya Tada, Belinda M Dcosta, Hao Zhou, et al.Journal for Immunotherapy of Cancer|April 24, 2024
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer modelsTakuya Tada, Thomas D Norton, Rebecca Leibowitz, et al.Viruses|June 24, 2022
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal AntibodiesHao Zhou, Belinda M Dcosta, Nathaniel R Landau, et al.Journal of Virology|August 17, 2005
Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylasesBärbel Schröfelbauer, Qin Yu, Samantha G Zeitlin, et al.Biorxiv : the Preprint Server for Biology|February 23, 2022
Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal AntibodiesHao Zhou, Takuya Tada, Belinda M Dcosta, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
A dominant block to HIV-1 replication at reverse transcription in simian cellsCarsten Münk, Stephanie M Brandt, Ginger Lucero, et al.Biorxiv : the Preprint Server for Biology|January 19, 2023
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor DecoyTakuya Tada, Belinda M Dcosta, Hao Zhou, et al.JCI Insight|August 16, 2022
Directly injected lentiviral vector-based T cell vaccine protects mice against acute and chronic viral infectionTakuya Tada, Thomas D Norton, Rebecca Leibowitz, et al.JCI Insight|April 10, 2023
Single-epitope T cell-based vaccine protects against SARS-CoV-2 infection in a preclinical animal modelTakuya Tada, Ju-Yi Peng, Belinda M Dcosta, et al.Pageof 9